Early research (Phase 1)Ended earlyNCT06225336
What this trial is testing
Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)
Who this might be right for
Microtia
Auregen Biotherapeutics, SA 2
Showing 20 of 33 results